Apyx Medical Corporation (APYX)
USD 1.0
(-13.79%)
USD 1.0
(-13.79%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 52.31 Million USD | 274.18% |
| 2022 | 13.98 Million USD | -4.96% |
| 2021 | 14.71 Million USD | 43.5% |
| 2020 | 10.25 Million USD | -23.59% |
| 2019 | 13.41 Million USD | 71.09% |
| 2018 | 7.84 Million USD | -12.44% |
| 2017 | 8.95 Million USD | 0.78% |
| 2016 | 8.88 Million USD | 10.48% |
| 2015 | 8.04 Million USD | -60.06% |
| 2014 | 20.13 Million USD | 70.01% |
| 2013 | 11.84 Million USD | 124.02% |
| 2012 | 5.28 Million USD | -13.64% |
| 2011 | 6.12 Million USD | 1.69% |
| 2010 | 6.02 Million USD | -6.38% |
| 2009 | 6.43 Million USD | -8.01% |
| 2008 | 6.99 Million USD | 244.55% |
| 2007 | 2.02 Million USD | -19.01% |
| 2006 | 2.5 Million USD | 36.97% |
| 2005 | 1.82 Million USD | 3.78% |
| 2004 | 1.76 Million USD | -1.22% |
| 2003 | 1.78 Million USD | -11.22% |
| 2002 | 2 Million USD | 27.33% |
| 2001 | 1.57 Million USD | 3.84% |
| 2000 | 1.51 Million USD | 14.28% |
| 1999 | 1.32 Million USD | -3.03% |
| 1998 | 1.37 Million USD | -14.97% |
| 1997 | 1.61 Million USD | -14.14% |
| 1996 | 1.87 Million USD | -41.08% |
| 1995 | 3.18 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 50.47 Million USD | 0.44% |
| 2024 Q1 | 50.25 Million USD | -3.95% |
| 2023 Q2 | 25.69 Million USD | 24.92% |
| 2023 Q4 | 52.31 Million USD | 102.31% |
| 2023 Q1 | 20.57 Million USD | 47.12% |
| 2023 FY | 52.31 Million USD | 274.18% |
| 2023 Q3 | 25.86 Million USD | 0.64% |
| 2022 Q1 | 13.15 Million USD | -10.59% |
| 2022 Q2 | 13.3 Million USD | 1.17% |
| 2022 Q3 | 13.05 Million USD | -1.93% |
| 2022 Q4 | 13.98 Million USD | 7.13% |
| 2022 FY | 13.98 Million USD | -4.96% |
| 2021 Q4 | 14.71 Million USD | 12.23% |
| 2021 FY | 14.71 Million USD | 43.5% |
| 2021 Q1 | 10.92 Million USD | 6.58% |
| 2021 Q2 | 11.91 Million USD | 9.04% |
| 2021 Q3 | 13.1 Million USD | 10.02% |
| 2020 Q1 | 11.68 Million USD | -12.9% |
| 2020 Q2 | 10.99 Million USD | -5.95% |
| 2020 Q3 | 11.07 Million USD | 0.78% |
| 2020 Q4 | 10.25 Million USD | -7.45% |
| 2020 FY | 10.25 Million USD | -23.59% |
| 2019 FY | 13.41 Million USD | 71.09% |
| 2019 Q4 | 13.41 Million USD | 31.41% |
| 2019 Q3 | 10.21 Million USD | 22.95% |
| 2019 Q2 | 8.3 Million USD | 7.98% |
| 2019 Q1 | 7.69 Million USD | -1.94% |
| 2018 Q1 | 8.64 Million USD | -3.49% |
| 2018 FY | 7.84 Million USD | -12.44% |
| 2018 Q4 | 7.84 Million USD | -64.05% |
| 2018 Q3 | 21.81 Million USD | 140.22% |
| 2018 Q2 | 9.08 Million USD | 5.06% |
| 2017 Q2 | 8.98 Million USD | 7.03% |
| 2017 Q3 | 8.18 Million USD | -8.94% |
| 2017 Q4 | 8.95 Million USD | 9.46% |
| 2017 FY | 8.95 Million USD | 0.78% |
| 2017 Q1 | 8.39 Million USD | -5.54% |
| 2016 FY | 8.88 Million USD | 10.48% |
| 2016 Q1 | 8.1 Million USD | 0.81% |
| 2016 Q2 | 8.28 Million USD | 2.22% |
| 2016 Q3 | 8.51 Million USD | 2.77% |
| 2016 Q4 | 8.88 Million USD | 4.32% |
| 2015 FY | 8.04 Million USD | -60.06% |
| 2015 Q3 | 8.5 Million USD | 6.02% |
| 2015 Q2 | 8.02 Million USD | -4.45% |
| 2015 Q1 | 8.39 Million USD | -58.31% |
| 2015 Q4 | 8.04 Million USD | -5.42% |
| 2014 Q4 | 20.13 Million USD | -6.44% |
| 2014 Q3 | 21.52 Million USD | 11.51% |
| 2014 Q2 | 19.3 Million USD | -6.76% |
| 2014 FY | 20.13 Million USD | 70.01% |
| 2014 Q1 | 20.7 Million USD | 74.77% |
| 2013 Q1 | 5.52 Million USD | 4.46% |
| 2013 Q3 | 6.26 Million USD | 0.37% |
| 2013 Q4 | 11.84 Million USD | 89.05% |
| 2013 FY | 11.84 Million USD | 124.02% |
| 2013 Q2 | 6.24 Million USD | 13.02% |
| 2012 Q4 | 5.28 Million USD | -3.56% |
| 2012 FY | 5.28 Million USD | -13.64% |
| 2012 Q1 | 5.65 Million USD | -7.71% |
| 2012 Q2 | 5.51 Million USD | -2.37% |
| 2012 Q3 | 5.48 Million USD | -0.62% |
| 2011 Q2 | 6.07 Million USD | 1.59% |
| 2011 FY | 6.12 Million USD | 1.69% |
| 2011 Q4 | 6.12 Million USD | 4.2% |
| 2011 Q3 | 5.87 Million USD | -3.23% |
| 2011 Q1 | 5.97 Million USD | -0.73% |
| 2010 Q1 | 6.72 Million USD | 4.55% |
| 2010 FY | 6.02 Million USD | -6.38% |
| 2010 Q3 | 6.18 Million USD | 2.2% |
| 2010 Q4 | 6.02 Million USD | -2.71% |
| 2010 Q2 | 6.05 Million USD | -9.93% |
| 2009 Q2 | 8.12 Million USD | 11.58% |
| 2009 FY | 6.43 Million USD | -8.01% |
| 2009 Q3 | 7.72 Million USD | -4.94% |
| 2009 Q4 | 6.43 Million USD | -16.73% |
| 2009 Q1 | 7.28 Million USD | 4.15% |
| 2008 Q2 | 2.58 Million USD | -1.05% |
| 2008 Q4 | 6.99 Million USD | 13.61% |
| 2008 FY | 6.99 Million USD | 244.55% |
| 2008 Q1 | 2.61 Million USD | 28.9% |
| 2008 Q3 | 6.15 Million USD | 137.79% |
| 2007 Q1 | 2.74 Million USD | 9.75% |
| 2007 FY | 2.02 Million USD | -19.01% |
| 2007 Q2 | 2.54 Million USD | -7.48% |
| 2007 Q3 | 2.41 Million USD | -5.03% |
| 2007 Q4 | 2.02 Million USD | -16.02% |
| 2006 Q1 | 1.95 Million USD | 6.97% |
| 2006 Q2 | 1.82 Million USD | -6.65% |
| 2006 Q3 | 2.01 Million USD | 10.08% |
| 2006 FY | 2.5 Million USD | 36.97% |
| 2006 Q4 | 2.5 Million USD | 24.6% |
| 2005 Q3 | 2.01 Million USD | -1.39% |
| 2005 Q4 | 1.82 Million USD | -9.44% |
| 2005 Q2 | 2.04 Million USD | -0.05% |
| 2005 Q1 | 2.04 Million USD | 16.28% |
| 2005 FY | 1.82 Million USD | 3.78% |
| 2004 Q2 | 2.07 Million USD | -5.16% |
| 2004 Q1 | 2.18 Million USD | 22.68% |
| 2004 Q4 | 1.76 Million USD | -3.83% |
| 2004 Q3 | 1.83 Million USD | -11.72% |
| 2004 FY | 1.76 Million USD | -1.22% |
| 2003 FY | 1.78 Million USD | -11.22% |
| 2003 Q1 | 2.52 Million USD | 25.44% |
| 2003 Q4 | 1.78 Million USD | 5.94% |
| 2003 Q3 | 1.68 Million USD | -14.14% |
| 2003 Q2 | 1.96 Million USD | -22.18% |
| 2002 Q2 | 1.72 Million USD | 8.92% |
| 2002 Q4 | 2 Million USD | 3.96% |
| 2002 FY | 2 Million USD | 27.33% |
| 2002 Q3 | 1.93 Million USD | 12.04% |
| 2002 Q1 | 1.58 Million USD | 0.37% |
| 2001 FY | 1.57 Million USD | 3.84% |
| 2001 Q1 | 1.49 Million USD | -1.32% |
| 2001 Q2 | 1.66 Million USD | 11.17% |
| 2001 Q3 | 1.6 Million USD | -3.65% |
| 2001 Q4 | 1.57 Million USD | -1.76% |
| 2000 Q4 | 1.51 Million USD | 12.24% |
| 2000 Q1 | 1.44 Million USD | 10.89% |
| 2000 FY | 1.51 Million USD | 14.28% |
| 2000 Q3 | 1.35 Million USD | -13.03% |
| 2000 Q2 | 1.55 Million USD | 8.01% |
| 1999 FY | 1.32 Million USD | -3.03% |
| 1999 Q1 | 1.4 Million USD | 0.0% |
| 1999 Q2 | 1.3 Million USD | -7.14% |
| 1999 Q3 | 1.3 Million USD | 0.0% |
| 1999 Q4 | 1.3 Million USD | 0.0% |
| 1998 Q1 | 1.5 Million USD | -6.25% |
| 1998 Q2 | 4.6 Million USD | 206.67% |
| 1998 Q3 | 1.5 Million USD | -67.39% |
| 1998 Q4 | 1.4 Million USD | -6.67% |
| 1998 FY | 1.37 Million USD | -14.97% |
| 1997 Q2 | 1.8 Million USD | -10.0% |
| 1997 Q1 | 2 Million USD | 5.26% |
| 1997 Q4 | 1.6 Million USD | -5.88% |
| 1997 FY | 1.61 Million USD | -14.14% |
| 1997 Q3 | 1.7 Million USD | -5.56% |
| 1996 Q2 | 3 Million USD | 0.0% |
| 1996 FY | 1.87 Million USD | -41.08% |
| 1996 Q3 | 3 Million USD | 0.0% |
| 1996 Q1 | 3 Million USD | -6.25% |
| 1996 Q4 | 1.9 Million USD | -36.67% |
| 1995 Q4 | 3.2 Million USD | 0.0% |
| 1995 FY | 3.18 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 51.25 Million USD | -2.076% |
| BrainsWay Ltd. | 15.31 Million USD | -241.635% |
| Cerus Corporation | 144.3 Million USD | 63.745% |
| Envoy Medical, Inc. | 9.4 Million USD | -456.456% |
| electroCore, Inc. | 8.94 Million USD | -484.885% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | -879.371% |
| IceCure Medical Ltd | 4.24 Million USD | -1131.881% |
| Inogen, Inc. | 121.38 Million USD | 56.898% |
| OrthoPediatrics Corp. | 72.56 Million USD | 27.898% |
| Lucid Diagnostics Inc. | 29.58 Million USD | -76.864% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | -1544.215% |
| MaxCyte, Inc. | 36.1 Million USD | -44.897% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | -2731.198% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -12201.984% |
| Orthofix Medical Inc. | 326.58 Million USD | 83.98% |
| PAVmed Inc | 57.13 Million USD | 8.434% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | -105.467% |
| RxSight, Inc. | 22.18 Million USD | -135.794% |
| Sight Sciences, Inc. | 46.43 Million USD | -12.667% |
| SI-BONE, Inc. | 61.05 Million USD | 14.303% |
| TELA Bio, Inc. | 59.16 Million USD | 11.576% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | 54.095% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | -407.006% |
| Acutus Medical, Inc. | 54.83 Million USD | 4.597% |
| Talis Biomedical Corporation | 29.22 Million USD | -79.024% |
| Spectral AI, Inc. | 12.4 Million USD | -321.885% |
| Nano-X Imaging Ltd. | 23.13 Million USD | -126.152% |
| CVRx, Inc. | 39.28 Million USD | -33.186% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | -337.512% |
| PetVivo Holdings, Inc. | 2.42 Million USD | -2053.625% |
| Bioventus Inc. | 589.79 Million USD | 91.129% |
| Venus Concept Inc. | 107.1 Million USD | 51.152% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | -1.268% |
| LivaNova PLC | 1.15 Billion USD | 95.458% |
| 908 Devices Inc. | 37.49 Million USD | -39.552% |
| Alphatec Holdings, Inc. | 703.48 Million USD | 92.563% |
| Nemaura Medical Inc. | 26.37 Million USD | -98.344% |
| NeuroPace, Inc. | 86.99 Million USD | 39.862% |
| LENSAR, Inc. | 22.4 Million USD | -133.469% |
| Cutera, Inc. | 518.12 Million USD | 89.902% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | -78.389% |
| BioSig Technologies, Inc. | 4.68 Million USD | -1016.713% |
| Anika Therapeutics, Inc. | 58.36 Million USD | 10.364% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | -143.475% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 97.616% |
| Axonics, Inc. | 82.35 Million USD | 36.476% |
| Outset Medical, Inc. | 190.91 Million USD | 72.596% |
| IRIDEX Corporation | 24.91 Million USD | -109.994% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | 57.796% |
| IRadimed Corporation | 20.73 Million USD | -152.306% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -3025.329% |
| INVO Bioscience, Inc. | 19.99 Million USD | -161.656% |
| Telesis Bio, Inc. | 40.87 Million USD | -28.001% |
| Viemed Healthcare, Inc. | 40.79 Million USD | -28.261% |
| Varex Imaging Corporation | 668.6 Million USD | 92.175% |
| Quipt Home Medical Corp. | 136.29 Million USD | 61.614% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -1364.67% |
| Pulmonx Corporation | 60.63 Million USD | 13.718% |
| Dynatronics Corporation | 11.78 Million USD | -344.121% |
| Modular Medical, Inc. | 2.27 Million USD | -2202.729% |
| ReShape Lifesciences Inc. | 4.06 Million USD | -1187.352% |
| Semler Scientific, Inc. | 6.27 Million USD | -734.418% |
| InMode Ltd. | 75.91 Million USD | 31.083% |
| Bruker Corporation | 2.83 Billion USD | 98.156% |
| Cytosorbents Corporation | 29.98 Million USD | -74.478% |
| DexCom, Inc. | 4.19 Billion USD | 98.753% |
| Align Technology, Inc. | 2.45 Billion USD | 97.868% |
| Viveve Medical, Inc. | 10.84 Million USD | -382.327% |
| ZimVie Inc. | 795.85 Million USD | 93.426% |
| Movano Inc. | 5.97 Million USD | -776.055% |
| Cytek Biosciences, Inc. | 104.6 Million USD | 49.985% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -12201.984% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | -337.512% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | 91.813% |
| Profound Medical Corp. | 12.66 Million USD | -313.063% |
| Insulet Corporation | 1.85 Billion USD | 97.18% |
| enVVeno Medical Corporation | 2.43 Million USD | -2048.583% |
| Surmodics, Inc. | 65.82 Million USD | 20.517% |
| iCAD, Inc. | 8 Million USD | -553.893% |
| Nuwellis, Inc. | 6.78 Million USD | -671.652% |
| Biotricity, Inc. | 35.91 Million USD | -45.654% |
| iRhythm Technologies, Inc. | 223.04 Million USD | 76.544% |
| Aethlon Medical, Inc. | 2.47 Million USD | -2009.895% |
| InspireMD, Inc. | 8.14 Million USD | -542.569% |
| PAVmed Inc. | 57.13 Million USD | 8.434% |
| BIOLASE, Inc. | 35.34 Million USD | -48.008% |
| Beyond Air, Inc. | 29.77 Million USD | -75.711% |
| FONAR Corporation | 57.45 Million USD | 8.945% |
| AxoGen, Inc. | 101.16 Million USD | 48.283% |
| Vivani Medical, Inc. | 25.03 Million USD | -108.971% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | 40.41% |
| Inari Medical, Inc. | 209.32 Million USD | 75.006% |
| UFP Technologies, Inc. | 118.04 Million USD | 55.68% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | -312.261% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | -2293.527% |
| Tenon Medical, Inc. | 5.56 Million USD | -839.788% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -2840.866% |
| Co-Diagnostics, Inc. | 17.63 Million USD | -196.686% |
| AdaptHealth Corp. | 3.15 Billion USD | 98.341% |
| Sintx Technologies, Inc. | 6.59 Million USD | -693.539% |
| NanoVibronix, Inc. | 2.68 Million USD | -1847.803% |
| Quanterix Corporation | 78.08 Million USD | 32.998% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -1364.67% |
| Sensus Healthcare, Inc. | 4.88 Million USD | -970.993% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | 94.992% |
| TransMedics Group, Inc. | 568.84 Million USD | 90.803% |
| ReWalk Robotics Ltd. | 16.68 Million USD | -213.619% |
| NeuroMetrix, Inc. | 1.33 Million USD | -3824.466% |
| Hyperfine, Inc. | 9.8 Million USD | -433.857% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | 79.093% |
| Biomerica, Inc. | 2.66 Million USD | -1864.626% |
| Bone Biologics Corporation | 831.4 Thousand USD | -6192.744% |
| AVITA Medical, Inc. | 19.86 Million USD | -163.362% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | -2550.78% |
| Silk Road Medical, Inc | 114.15 Million USD | 54.171% |